Total Payments
$2,392
2024 Payments
$914.00
Companies
19
Transactions
96
Medicare Patients
584
Medicare Billing
$85,519
Payment Breakdown by Category
Food & Beverage$2,392 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,392 | 96 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $756.04 | 32 | $0 (2024) |
| GENZYME CORPORATION | $439.61 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $241.53 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $193.62 | 7 | $0 (2024) |
| Genentech USA, Inc. | $130.75 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $125.00 | 1 | $0 (2018) |
| Breas Medical, Inc. | $97.93 | 1 | $0 (2024) |
| Amgen Inc. | $87.35 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $87.35 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $43.44 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $914.00 | 40 | GlaxoSmithKline, LLC. ($160.30) |
| 2023 | $897.52 | 42 | GENZYME CORPORATION ($299.76) |
| 2022 | $198.65 | 10 | GlaxoSmithKline, LLC. ($114.55) |
| 2021 | $139.88 | 2 | GlaxoSmithKline, LLC. ($120.18) |
| 2020 | $116.47 | 1 | GlaxoSmithKline, LLC. ($116.47) |
| 2018 | $125.00 | 1 | Janssen Pharmaceuticals, Inc ($125.00) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Breas Medical, Inc. | Vivo 45 LS (Device) | Food and Beverage | In-kind items and services | $97.93 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $3.78 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | SANOFI PASTEUR INC. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: Immunology | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $109.62 | General |
| Category: Respiratory | ||||||
| 07/01/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: PULMONOLOGY | ||||||
| 06/17/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: Inflammation | ||||||
| 05/22/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $18.32 | General |
| Category: HFCWO | ||||||
| 05/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Immunology | ||||||
| 04/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Inflammation | ||||||
| 04/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Immunology | ||||||
| 04/10/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Respiratory | ||||||
| 04/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: RESPIRATORY | ||||||
| 04/01/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Immunology | ||||||
| 04/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: RESPIRATORY | ||||||
| 04/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.79 | General |
| Category: RESPIRATORY | ||||||
| 03/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: IMMUNOLOGY | ||||||
| 03/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Immunology | ||||||
| 03/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Immunology | ||||||
| 02/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 298 | 423 | $109,945 | $36,961 |
| 2022 | 7 | 198 | 302 | $83,990 | $32,541 |
| 2021 | 5 | 88 | 156 | $37,022 | $16,017 |
Total Patients
584
Total Services
881
Medicare Billing
$85,519
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 19 | 41 | $19,475 | $6,529 | 33.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 47 | 75 | $14,250 | $6,419 | 45.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 48 | 59 | $20,650 | $6,012 | 29.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 91 | $11,830 | $5,211 | 44.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 53 | 69 | $18,975 | $4,684 | 24.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 35 | $8,575 | $3,209 | 37.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $7,200 | $2,516 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 17 | 17 | $5,950 | $1,593 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 16 | $3,040 | $787.68 | 25.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 30 | 65 | $30,875 | $11,422 | 37.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 44 | 75 | $14,250 | $6,218 | 43.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 43 | $5,590 | $2,531 | 45.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 18 | 23 | $7,290 | $2,453 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 23 | $5,605 | $2,425 | 43.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 16 | $5,410 | $2,365 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 31 | $7,265 | $2,204 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $5,010 | $1,695 | 33.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $2,695 | $1,230 | 45.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 12 | 29 | $13,775 | $5,366 | 39.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 23 | 51 | $9,690 | $4,414 | 45.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 21 | $5,197 | $2,397 | 46.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 17 | 33 | $4,290 | $1,988 | 46.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 15 | 22 | $4,070 | $1,854 | 45.5% |
About Dr. Daniel Kramer, M.D
Dr. Daniel Kramer, M.D is a Pulmonary Disease healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2015. The National Provider Identifier (NPI) number assigned to this provider is 1447647177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Kramer, M.D has received a total of $2,392 in payments from pharmaceutical and medical device companies, with $914.00 received in 2024. These payments were reported across 96 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,392).
As a Medicare-enrolled provider, Kramer has provided services to 584 Medicare beneficiaries, totaling 881 services with total Medicare billing of $85,519. Data is available for 3 years (2021–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Philadelphia, PA
- Active Since 04/21/2015
- Last Updated 08/12/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1447647177
Products in Payments
- DUPIXENT (Biological) $554.17
- TRELEGY ELLIPTA (Drug) $391.98
- NUCALA (Biological) $364.06
- TEZSPIRE (Biological) $220.35
- OFEV (Drug) $200.11
- Xolair (Biological) $130.75
- XARELTO (Drug) $125.00
- Vivo 45 LS (Device) $97.93
- Adempas (Drug) $43.44
- CHARTIS CATHETER (Device) $36.45
- ARALAST (Biological) $21.70
- SPIRIVA RESPIMAT (Drug) $21.31
- STIOLTO RESPIMAT (Drug) $20.11
- GENERAL PULMONARY (Device) $19.70
- Hillrom - Life 2000 Ventilation System (Device) $18.67
- SMARTVEST (Device) $18.32
- Arikayce (Drug) $17.64
- ZERBAXA (Drug) $16.74
- Flexitouch Plus (Device) $12.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Philadelphia
Gerard Criner, Md, MD
Pulmonary Disease — Payments: $945,674
Pulmonary Disease $945,674
Jeffrey Edelson, M.d, M.D
Pulmonary Disease — Payments: $437,125
Pulmonary Disease $437,125
Steven Geller, Do, DO
Pulmonary Disease — Payments: $251,222
Pulmonary Disease $251,222
Parth Rali, Md, MD
Pulmonary Disease — Payments: $232,570
Pulmonary Disease $232,570
Boyd Hehn, Md, MD
Pulmonary Disease — Payments: $139,719
Pulmonary Disease $139,719
Edward Schulman, Md, MD
Pulmonary Disease — Payments: $132,370
Pulmonary Disease $132,370